Bruker (BRKR) Asset Writedowns and Impairment (2010 - 2025)

Bruker's Asset Writedowns and Impairment history runs 13 years deep, the most recent figure standing at $4.8 million for Q4 2025.

• Quarterly Asset Writedowns and Impairment rose 380.0% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.0 million (up 15.04% YoY) and the FY2025 annual result came in at $152.3 million, up 434.39% from the prior year.
• Asset Writedowns and Impairment was $4.8 million for Q4 2025 at Bruker, up from $1.0 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $20.2 million in Q2 2024 and bottomed at -$1.9 million in Q3 2022.
• A 4-year average of $4.5 million and a median of $2.0 million in 2022 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment surged 11500.0% — and 2024, when it sank 79.71%.
• Bruker's Asset Writedowns and Impairment stood at $1.6 million in 2022, then soared by 68.75% to $2.7 million in 2023, then slumped by 62.96% to $1.0 million in 2024, then surged by 380.0% to $4.8 million in 2025.
• Business Quant data shows BRKR's Asset Writedowns and Impairment at $4.8 million in Q4 2025, $1.0 million in Q4 2024, and $20.2 million in Q2 2024.